I agree that this site is using cookies. You can find further informations here.
X
Haemmerle, M.
~ 200  results:
Search for persons X
?
1

Aspirin-PC is a novel, safe and efficacious compound in ova..:

Bottsford-Miller, J.N. ; Haemmerle, M. ; Wagner, M.J....
Gynecologic Oncology.  145 (2017)  - p. 85-86 , 2017
Link: https://doi.org/10.1016/..
 
?
2

Fluidized Bed Steam Generators for Direct Particle Absorpti..:

Schwaiger, K. ; Haider, M. ; Haemmerle, M....
Energy Procedia.  69 (2015)  - p. 1421-1430 , 2015
Link: https://doi.org/10.1016/..
 
?
3

Minimum alveolar concentration for halothane in children wi..:

Frei, F. J. ; Haemmerle, M. H. ; Brunner, R..
Anaesthesia.  52 (1997)  11 - p. 1056-1060 , 1997
Link: https://doi.org/10.1111/..
 
?
4

Sorption of Natural Siderophores onto Clinoptilolite-Tuff a..:

Haemmerle, Mona M. ; Tschegg, Cornelius
Minerals.  13 (2023)  5 - p. 611 , 2023
Link: https://doi.org/10.3390/..
 
?
5

Adsorption and Release Characteristics of Purified and Non-..:

Haemmerle, Mona M. ; Fendrych, Joachim ; Matiasek, Elisabeth.
Crystals.  11 (2021)  11 - p. 1343 , 2021
Link: https://doi.org/10.3390/..
 
?
6

Sorption of Natural Siderophores onto Clinoptilolite-Tuff a..:

Mona M. Haemmerle ; Cornelius Tschegg
https://www.mdpi.com/2075-163X/13/5/611.  , 2023
Link: https://doi.org/10.3390/..
 
?
7

Sorption of Natural Siderophores onto Clinoptilolite-Tuff a..:

Mona M. Haemmerle ; Cornelius Tschegg
Clays and Engineered Mineral Materials.  , 2023
Link: https://doi.org/10.3390/..
 
?
8

Adsorption and Release Characteristics of Purified and Non-..:

Mona M. Haemmerle ; Joachim Fendrych ; Elisabeth Matiasek.
https://www.mdpi.com/2073-4352/11/11/1343.  , 2021
Link: https://doi.org/10.3390/..
 
?
9

Adsorption and Release Characteristics of Purified and Non-..:

Mona M. Haemmerle ; Joachim Fendrych ; Elisabeth Matiasek.
Inorganic Crystalline Materials.  , 2021
Link: https://doi.org/10.3390/..
 
?
10

Fast symptom improvement and favorable safety profile with ..:

Bérard, F. ; Saini, S. ; Giménez-Arnau, A....
Revue Française d'Allergologie.  64 (2024)  - p. 103855 , 2024
Link: https://doi.org/10.1016/..
 
?
11

Analysis of safety data of remibrutinib from completed phas..:

Bérard, F. ; Saini, S. ; Maurer, M....
Revue Française d'Allergologie.  64 (2024)  - p. 103861 , 2024
Link: https://doi.org/10.1016/..
 
?
12

Alcohol withdrawal and amphetamine co-use in an animal mode..:

Shah, Pooja M. ; Pillarella, Nicholas R. ; Telatin, Marta...
The American Journal of Drug and Alcohol Abuse.  50 (2024)  3 - p. 334-344 , 2024
Link: https://doi.org/10.1080/..
 
?
13

REMIBRUTINIB ACHIEVES CLINICALLY SIGNIFICANT RESPONSE IN CH..:

Clore, L. ; Maurer, M. ; Wells, M....
Annals of Allergy, Asthma & Immunology.  131 (2023)  5 - p. S37-S38 , 2023
Link: https://doi.org/10.1016/..
 
?
14

REMIBRUTINIB TREATMENT IMPROVES HIVE SEVERITY IN PATIENTS W..:

Sitz, K. ; Giménez-Arnau, A. ; Hayama, K....
Annals of Allergy, Asthma & Immunology.  131 (2023)  5 - p. S11 , 2023
Link: https://doi.org/10.1016/..
 
?
15

ANALYSIS OF SAFETY DATA OF REMIBRUTINIB FROM COMPLETED PHAS..:

Saini, S. ; Maurer, M. ; Giménez-Arnau, A....
Annals of Allergy, Asthma & Immunology.  131 (2023)  5 - p. S30-S31 , 2023
Link: https://doi.org/10.1016/..
 
1-15